Reading the tape
NYSE: ARDT
Ardent Health Partners, LLC
Healthcare · Medical - Care Facilities
Market Cap
$1.43B
52w High
$15.48
52w Low
$8.07
P/E
10.35
Volume
9.57K
Outstanding Shares
143.10M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -24.22%Revenue (TTM): 6.01%FCF (TTM): 99.52%
What changed
The stock fell 24.22% over the last year. Revenue grew 6.01% over the trailing twelve months. Operating margin moved from 5.46% to 8.91%. Free cash flow grew 99.52% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently 8.91%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States.
CEOMartin J. Bonick
SectorHealthcare
IndustryMedical - Care Facilities
Employees19,200
IPO dateJul 18, 2024
Valuation
Forward P/E—
EV/EBITDA5.81
Enterprise value$2.8B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-0.08%
Gross margin97.54%▲17.97%vs FY2024
Operating margin8.91%▼24.31%vs FY2024
ROE8.05%▼56.68%vs FY2024
Analyst consensus
RatingBuy
Target price$13.33▲33.50%
8
Buy
3
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $0.18 · Revenue est $1.58B
View